Cours Recipharm publ AB Swiss Exchange
Actions
SE0005757267
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- SEK | - |
2023 | Synokem Pharmaceuticals Limited a acquis 74% des parts de Nitin Lifesciences Limited auprès de Recipharm AB (publ). | CI |
2023 | Recipharm annonce des changements au niveau de la direction | CI |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03/04/23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01/03/21 |
Director/Board Member | 67 | 01/01/21 | |
Richard Ridinger
CHM | Chairman | 66 | 01/03/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+14,95% | 74,45 Md | |
+11,35% | 9,18 Md | |
+60,16% | 5,03 Md | |
-12,85% | 5,02 Md | |
+1,60% | 3,82 Md | |
-19,20% | 2,41 Md | |
+18,23% | 2,39 Md | |
-27,46% | 2,27 Md | |
+24,62% | 2,26 Md |
- Bourse
- Actions
- Action RECI B
- Action